Yum Brands Insider Sold Shares Worth $859,223, According to a Recent SEC Filing-February 2024-www.financetom.com

Yum Brands Insider Sold Shares Worth $859,223, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Yum Brands Insider Sold Shares Worth $859,223, According to a Recent SEC Filing

May 6, 2024 8:45 AM

11:23 AM EDT, 05/06/2024 (MT Newswires) -- Paget Leonard Alves, Director, on May 02, 2024, sold 6,309 shares in Yum Brands ( YUM ) for $859,223.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1041061/000112760224014218/xslF345X03/form4.xml

Price: 137.00, Change: +2.66, Percent Change: +1.98

Previous page： Liberty Energy Insider Sold Shares Worth $903,000, According to a Recent SEC Filing Next page： AstraZeneca's Imfinzi improves survival in late-stage lung cancer trial

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Liberty Energy Insider Sold Shares Worth $903,000, According to a Recent SEC Filing

Apr 5, 2024

09:44 AM EDT, 04/05/2024 (MT Newswires) -- Christopher A Wright, Director, Chairman of the Board and CEO, around April 03, 2024, sold 40,000 shares in Liberty Energy (LBRT) for $903,000. Following the Form 4 filing with the SEC, Wright has control over a total of 2,858,814 shares of the company, with 2,858,814 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1694028/000169402824000023/xslF345X03/wk-form4_1712270224.xml Price: 22.66,...

AstraZeneca's Imfinzi improves survival in late-stage lung cancer trial

Apr 5, 2024

April 5 (Reuters) - AstraZeneca ( AZN ) said on Friday its blockbuster cancer drug Imfinzi helped improve survival in patients in the early stages of an aggressive type of lung cancer, making it the first such immunotherapy to meet two key trial goals. In a late-stage trial, the drug demonstrated statistically significant and clinically meaningful improvement in both overall...

Atlassian Insider Sold Shares Worth $1,615,066, According to a Recent SEC Filing

Apr 5, 2024

09:53 AM EDT, 04/05/2024 (MT Newswires) -- Michael Cannon-brookes, 10% Owner, Director, Co-CEO, Co-Founder, on April 03, 2024, sold 8,241 shares in Atlassian ( TEAM ) for $1,615,066. Following the Form 4 filing with the SEC, Cannon-brookes has control over a total of 490,065 shares of the company, with 490,065 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1650372/000156218024003308/xslF345X03/primarydocument.xml Price: 194.03, Change: +1.71, Percent...

What's Going On With Uber Technologies Shares Friday?

Apr 5, 2024

Uber Technologies ( UBER ), Inc. shares are trading higher in the morning session on Friday. Yesterday, the company entered into a new nationwide partnership with The Vitamin Shoppe, bringing the New Jersey-based health and wellness retailer’s selection to the Uber Eats app. About 700 locations of The Vitamin Shoppe and Super Supplements are now available for ordering on Uber Eats across...